Rick Doblin’s Vision For The Future Of Psychedelic Therapies

2021 ⸱ 

Rick Doblin, PhD

Share

Rick Doblin, PhD, founder of the Multidisciplinary Association for Psychedelic Studies (MAPS), highlights what MAPS is doing to bring psychedelics into mainstream medicine and how these substances might help us navigate the particular urgency of our times.

About the speaker(s)

Rick Doblin, Ph.D., is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in Public Policy from Harvard’s Kennedy School of Government, Rick studied with Dr. Stanislav Grof and was among the first to be certified as a Holotropic Breathwork practitioner. His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. Today, MAPS is designing or sponsoring psychedelic psychotherapy drug development research in over a dozen countries and has raised more than $70 million in donations.

Help us change the way we die

Join the Movement

Get the latest news and fresh ideas from the frontlines of all things end of life.